• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarey Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3360.0
  • ISIN : INE198H01019
33.51 -3 (-8.19%)
  • As on 31 Mar 2025 (EOD)
  • Today’s Low

    32.85
  • Today’s High

    37.29
  • Open

    36.00
  • Perv Close

    36.50
  • 52W Low

    31.35
  • 52W High

    74.80

Key Indicators

  • P/E(TTM)

    16.77

  • Mar.Cap (₹Cr.)

    95.02

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.32

  • Debt-Equity Ratio

    -8.19

  • AGM Date

    28-Mar-2025

  • EPS

    2.01

  • P/E Ratio

    16.77

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    95.02

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    28.35

  • BV (₹)

    48.30

  • Sales( ₹ in Cr.)

    395.62

  • NP (in Cr.)

    4.68

  • NP Var(%)

    24.0

  • Div%

    0.0

  • CPS (₹)

    2.30

  • EPS (₹)

    1.70

  • Traded Value (₹ in Lakhs)

    95.58

  • 52 Week High

    74.80

  • 52 Week Low

    31.35

  • Price BSE

    34.0

  • Price NSE

    34.00

  • Market Capital( in Cr.)

    95.58

  • P/C Ratio

    15.10

  • P/E Ratio

    20.60

  • Price Vs.BV

    1.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 395.62 418.96 492.76 348.42 300.09 354.74
Excise Duty 393.59 414.25 492.68 348.42 300.09 354.74
Net Sales 395.62 418.96 492.76 348.42 300.09 354.74
Other Income 6.96 2.73 2.67 7.01 6.69 4.34
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 402.58 421.69 495.43 355.43 306.78 359.08
EXPENDITURE :
Raw Materials 393.59 414.25 492.68 348.42 300.09 354.74
Power & Fuel Cost 393.59 414.25 492.68 348.42 300.09 354.74
Employee Cost 0.72 0.81 0.98 0.40 0.40 0.47
Other Manufacturing Expenses 0.26 0.71 0.50 0.20 0.12 0.01
Selling & Administrative Expenses 7.71 4.40 6.64 3.73 4.88 3.77
Miscellaneous Expenses 0.26 0.71 0.50 0.20 0.12 0.01
Less : Pre-operative Expenses Capitalised :
Total Expenditure 397.24 415.68 485.39 347.13 299.54 350.09
Operating Profit 0.58 1.47 7.14 4.95 1.28 1.63
Interest 4.38 2.87 2.04 2.44 1.79 2.23
Gross Profit 5.34 6.01 10.04 8.30 7.24 8.99
Depreciation 1.70 1.57 1.99 0.92 0.89 1.01
Profit Before Tax 5.34 6.01 10.04 8.30 7.24 8.99
Tax 1.33 1.78 2.61 1.66 1.50 2.25
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.67 -0.04 -0.11 0.12 -0.05 0.19
Reported Net Profit 4.68 3.77 6.55 6.51 5.79 6.54
Extraordinary Items 5.34 6.01 10.04 8.30 7.24 8.99
Adjusted Net Profit 4.68 3.77 6.55 6.51 5.79 6.54
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.23
P & L Balance carried down 4.68 3.77 6.55 6.51 5.79 6.54
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 1.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.10
Earnings Per Share-Unit Curr 1.84 1.49 2.72 2.79 2.48 2.80
Book Value 0.00 0.00 0.00 0.00 0.00 0.23
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.23

Shareholding Pattern

  • Promoter Group

    44.80%

  • Public Share Holding

    55.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 4,020,000 14.18 4,020,000 2
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,682,443 30.62 8,682,443 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,702,443 44.80 12,702,443 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 663,938 2.34 663,938 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 663,938 2.34 663,938 2
2] Non Institution
Bodies Corporate 1,514,015 5.34 1,492,535 90
Clearing Members 1,270 0.00 1,270 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 107,341 0.38 107,341 100
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 458,702 1.62 458,702 239
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,745,128 23.79 6,745,128 82
Individuals holding nominal share capital up to Rs. 1 lakh 5,977,701 21.08 5,486,782 15,753
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 123,605 0.44 123,605 10
Sub Total 14,987,922 52.86 14,475,523 16,279
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 28,354,303 100.00 27,841,904 16,288

Company Background

Aarey Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarey Drugs & Pharmaceuticals Ltd
  • BSE Code : 3360.0
  • ISIN : INE198H01019
  • Incorporation Year

    1990

  • Registered Office

    E-34 MIDC Tarapur
    Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-23455543

  • FAX

  • Chairman

    Mihir R Ghatalia

  • Managing Director

    Mihir R Ghatalia

  • Company Secretary

    KAILASH CHAND JETHLIA

  • Auditor

    Motilal & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarey Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarey Drugs 33.71 402.58 395.62 16.77 6.09
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92